Finzati - Logo
ZYBT logo

Zhengye Biotechnology Holding Limited

ZYBT • Drug Manufacturers - Specialty & Generic
$1.61
▼ -0.02 (-1.23%)
Current price
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$76.30M
Growth
-100.0%
Cash Flow
3/5
Trend
Mostly stable
Evidence
Manageable debt level · 0.3Weak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.61
Change-1.23%
Shares Out47.39M
Market Cap$76.30M
52W Range0.68 - 13.08
Beta-2.39
P/E0.00
P/S0.00
P/B0.00
P/FCF0.00
EV/Sales0.21
EV/EBITDA-0.58

Investment DNA

How strong this company looks for long-term investors

41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
54/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Manageable debt level · 0.3Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 1/7/2025
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 0.00
Debt / Equity i: 0.30
Operating Margin: -58.66%
Net Margin: -59.97%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: 0.30
Current Ratio: 1.14
Quick Ratio: 0.82
Status: Moderate

Insider Transactions

Recent executive and insider activity

Jiang Ping (PiJi)
Transaction: 06/25/2026
OTHER
Change
0
Price
Not reported
Filing
06/25/2026
Type
OTHER
Wang Ping (nmn)
Transaction: 06/25/2026
OTHER
Change
0
Price
Not reported
Filing
06/25/2026
Type
OTHER
Song Songlin
Transaction: 06/25/2026
OTHER
Change
0
Price
Not reported
Filing
06/25/2026
Type
OTHER